Page last updated: 2024-12-09

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2734059
SCHEMBL ID28467
MeSH IDM0441687

Synonyms (45)

Synonym
AC-1402
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5
dmtmm
D2919
4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methyl morpholinium chloride
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride
FT-0650130
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium chloride
4-(4,6-dimethoxy[1,3,5]triazin-2-yl)-4-methylmorpholinium chloride
kunishima coupling reagent
AKOS015909830
AM83822
SCHEMBL28467
4-(4,6-dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride
BMTZEAOGFDXDAD-UHFFFAOYSA-M
4-(dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methylmorpholinium chloride
dmt-mm
4-(4,6-dimethoxy-[1,3,5]triazin-2-yl)-4-methyl-morpholin-4-ium chloride
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)4-methylmorpholinium chloride
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methymorpholinium chloride
J-650384
4-(dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-iumchloride
morpholinium, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-, chloride
CS-0017161
J-803065
J-513446
DTXSID50370104
mfcd03613550
dmt-mm.nh2o
D72520
c10h17cln4o3
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (dmtmm)
dmtmm?4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium;chloride
FS-4572
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (dmtmm)
n-(4
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-iumchloride
bld6n6av8l ,
morpholinium, 4-(4,6-dimethoxy-s-triazin-2-yl)-4-methyl-, chloride
4-(4,6-dimethoxy-s-triazin-2-yl)-4-methylmorpholinium chloride
unii-bld6n6av8l
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (33.33)29.6817
2010's15 (55.56)24.3611
2020's3 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.00 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.57%)5.53%
Reviews1 (3.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]